Skip Navigation
Skip to contents

Diabetes Metab J : Diabetes & Metabolism Journal

Search
OPEN ACCESS

Search

Page Path
HOME > Search
1 "Obesity, metabolically benign"
Filter
Filter
Article category
Keywords
Publication year
Authors
Funded articles
Original Article
Metabolic Risk/Epidemiology
Article image
Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes
Hyun-Woong Cho, Wankyo Chung, Shinje Moon, Ohk-Hyun Ryu, Min Kyung Kim, Jun Goo Kang
Diabetes Metab J. 2021;45(2):209-218.   Published online July 10, 2020
DOI: https://doi.org/10.4093/dmj.2019.0223
  • 9,973 View
  • 226 Download
  • 25 Web of Science
  • 26 Crossref
AbstractAbstract PDFSupplementary MaterialPubReader   ePub   
Background

This study aimed to assess the effects of sarcopenia and A Body Shape Index (ABSI) on cardiovascular disease (CVD) risk according to obesity phenotypes.

Methods

We used data from the National Health and Nutrition Examination Survey 1999 to 2012. A total of 25,270 adults were included and classified into the following groups: metabolically healthy normal weight (MHNW), metabolically healthy overweight/obese (MHO), metabolically unhealthy normal weight (MUNW), and metabolically unhealthy overweight/obese (MUO). Sarcopenia was defined as the appendicular skeletal mass index <7 kg/m2 in men and <5.5kg/m2 in women. A multivariate logistic regression analysis was performed to evaluate the odds ratio (OR) of sarcopenia and ABSI for CVD events according to the obesity phenotype.

Results

The MHNW participants with sarcopenia had higher risk for CVD than those without sarcopenia (OR, 2.69; 95% confidence interval [CI], 1.56 to 4.64). In the analysis with MHNW participants without sarcopenia as a reference, the participants with sarcopenia showed a higher OR for CVD than those without sarcopenia in both MHO (OR in participants without sarcopenia, 3.31; 95% CI, 1.94 to 5.64) (OR in participants with sarcopenia, 8.59; 95% CI, 2.63 to 28.04) and MUO participants (OR in participants without sarcopenia, 5.11; 95% CI, 3.21 to 8.15) (OR in participants with sarcopenia, 8.12; 95% CI, 4.04 to 16.32). Participants within the second and third tertiles of ABSI had higher ORs for CVDs than the counterpart of obesity phenotypes within the first tertile.

Conclusion

These results suggest that clinical approaches that consider muscle and body shape are required.

Citations

Citations to this article as recorded by  
  • Association of low muscle mass and obesity with increased all‐cause and cardiovascular disease mortality in US adults
    Donghyun Kim, Junghoon Lee, Raekil Park, Chang‐Myung Oh, Shinje Moon
    Journal of Cachexia, Sarcopenia and Muscle.2024; 15(1): 240.     CrossRef
  • Metabolic-associated fatty liver disease and sarcopenia: A double whammy
    Aditya Viswanath, Sherouk Fouda, Cornelius James Fernandez, Joseph M Pappachan
    World Journal of Hepatology.2024; 16(2): 152.     CrossRef
  • Association between relative muscle strength and cardiovascular disease among middle-aged and older adults in China
    Jin-jin Ji, Meng-jie Zhao, Meng-li Xiao, Hui-e Zhang, Qin Tan, Yu-rong Cheng, Fang Lu
    BMC Public Health.2024;[Epub]     CrossRef
  • In Silico İnvestigating Scutellarin, Plantago Majör Flavonoid as an Alternative to Orlistat
    İsmail Keleş, Alpaslan Bayrakdar, Nermin Olgun
    Caucasian Journal of Science.2024; 11(1): 38.     CrossRef
  • Association between a body shape index and female infertility: a cross-sectional study
    Qian Yang, Jianxiong Wuliu, Lingling Zeng, Jinfa Huang, Guihua Tang, Junchao Zhang, Kedan Liao, Kaixian Deng
    BMC Women's Health.2024;[Epub]     CrossRef
  • Relationship between Body Adiposity Indices and Reversal of Metabolically Unhealthy Obesity 6 Months after Roux-en-Y Gastric Bypass
    Mariana Luna, Silvia Pereira, Carlos Saboya, Andrea Ramalho
    Metabolites.2024; 14(9): 502.     CrossRef
  • Association between Sarcopenic Obesity and Arterial Stiffness in Korean Adults
    Hye Rang Bak, Hye-Jin Jang, Hyun-Min Koh, Nak Gyeong Ko, Young Hye Cho
    Journal of Clinical Medicine.2024; 13(20): 6108.     CrossRef
  • The Abdominal Adiposity Index (A Body Shape Index) Predicts 10-Year All-Cause Mortality in Elderly Active Non-Obese Subjects
    Alessio Nunnari, Filippo Giorgio Di Girolamo, Kaja Teraž, Nicola Fiotti, Boštjan Šimunič, Filippo Mearelli, Rado Pišot, Gianni Biolo
    Journal of Clinical Medicine.2024; 13(20): 6155.     CrossRef
  • Association of Myosteatosis with Nonalcoholic Fatty Liver Disease, Severity, and Liver Fibrosis Using Visual Muscular Quality Map in Computed Tomography
    Hwi Seung Kim, Jiwoo Lee, Eun Hee Kim, Min Jung Lee, In Young Bae, Woo Je Lee, Joong-Yeol Park, Hong-Kyu Kim, Chang Hee Jung
    Diabetes & Metabolism Journal.2023; 47(1): 104.     CrossRef
  • Additive impact of diabetes and sarcopenia on all-cause and cardiovascular mortality: A longitudinal nationwide population-based study
    Eyun Song, Soon Young Hwang, Min Jeong Park, Ahreum Jang, Kyeong Jin Kim, Ji Hee Yu, Nam Hoon Kim, Hye Jin Yoo, Ji A. Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Kyung Mook Choi
    Metabolism.2023; 148: 155678.     CrossRef
  • Association between a body shape index and abdominal aortic calcification in general population: A cross-sectional study
    Wei Li, Zhenwei Wang, Min Li, Jing Xie, Jing Gong, Naifeng Liu
    Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
  • Metabolic Impact of Frailty Changes Diabetes Trajectory
    Alan J. Sinclair, Ahmed H. Abdelhafiz
    Metabolites.2023; 13(2): 295.     CrossRef
  • Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomography
    Yun Kyung Cho, Han Na Jung, Eun Hee Kim, Min Jung Lee, Joong‐Yeol Park, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung
    Obesity.2023; 31(6): 1547.     CrossRef
  • Metabolic Characteristics of Frail Older People with Diabetes Mellitus—A Systematic Search for Phenotypes
    Ahmed H. Abdelhafiz, Grace L. Keegan, Alan J. Sinclair
    Metabolites.2023; 13(6): 705.     CrossRef
  • Risk of Cardiovascular Diseases Among Different Metabolic Obesity Phenotypes: A Prospective Observational Study
    Xiaowei Liu, Chan Yang, Yuanyuan Dang, Zhenqi Chang, Juan Li, Yi Zhao, Yuhong Zhang
    Metabolic Syndrome and Related Disorders.2023; 21(6): 306.     CrossRef
  • Effect of Hypoxia Conditioning on Body Composition in Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis
    Zhijian He, Lijun Qiang, Yusheng Liu, Wenfeng Gao, Tao Feng, Yang Li, Bing Yan, Olivier Girard
    Sports Medicine - Open.2023;[Epub]     CrossRef
  • Association Between a Body Shape Index and Subclinical Carotid Atherosclerosis in Population Free of Cardiovascular and Cerebrovascular Diseases
    Xiaotian Ma, Lihong Chen, Wenchao Hu, Lanjie He
    Journal of Atherosclerosis and Thrombosis.2022; 29(8): 1140.     CrossRef
  • Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease
    Vittoria Zambon Azevedo, Cristina Alina Silaghi, Thomas Maurel, Horatiu Silaghi, Vlad Ratziu, Raluca Pais
    Frontiers in Nutrition.2022;[Epub]     CrossRef
  • Identification of sarcopenic obesity in adults undergoing orthopaedic surgery: Relationship between “a body shape index” (ABSI) and fat-free mass. A cross -sectional study
    Ana Tomažič, Boštjan Žvanut, Lilijana Vouk Grbac, Mihaela Jurdana, Fatih Özden
    PLOS ONE.2022; 17(6): e0269956.     CrossRef
  • Associations of Dynapenic Obesity and Sarcopenic Obesity with the Risk of Complications in COVID-19
    Laura Pérez-Campos Mayoral, Carlos Alberto Matias-Cervantes, Eduardo Pérez-Campos, Carlos Romero Díaz, Luis Ángel Laguna Barrios, María del Socorro Pina Canseco, Margarito Martínez Cruz, Eduardo Pérez-Campos Mayoral, Carlos Josué Solórzano Mata, Francisco
    International Journal of Molecular Sciences.2022; 23(15): 8277.     CrossRef
  • Sex Differences in Adiposity and Cardiovascular Diseases
    Haoyun Li, Daniels Konja, Luyao Wang, Yu Wang
    International Journal of Molecular Sciences.2022; 23(16): 9338.     CrossRef
  • The Applicability of the ESPEN and EASO-Defined Diagnostic Criteria for Sarcopenic Obesity in Japanese Patients after Stroke: Prevalence and Association with Outcomes
    Yoshihiro Yoshimura, Hidetaka Wakabayashi, Fumihiko Nagano, Ayaka Matsumoto, Sayuri Shimazu, Ai Shiraishi, Yoshifumi Kido, Takahiro Bise
    Nutrients.2022; 14(19): 4205.     CrossRef
  • The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease
    Maobin Kuang, Guotai Sheng, Chong Hu, Song Lu, Nan Peng, Yang Zou
    Lipids in Health and Disease.2022;[Epub]     CrossRef
  • Sarcopenia and cardiovascular disease in patients with and without kidney disease: what do we know?
    Ozkan Gungor, Mustafa Sevinc, Sena Ulu, Ismail Kocyigit
    International Urology and Nephrology.2022; 55(5): 1161.     CrossRef
  • Skeletal Muscle Should Not Be Overlooked
    Ji A Seo
    Diabetes & Metabolism Journal.2021; 45(2): 173.     CrossRef
  • The Role of Sarcopenic Obesity in Cancer and Cardiovascular Disease: A Synthesis of the Evidence on Pathophysiological Aspects and Clinical Implications
    Erika Aparecida Silveira, Rômulo Roosevelt da Silva Filho, Maria Claudia Bernardes Spexoto, Fahimeh Haghighatdoost, Nizal Sarrafzadegan, Cesar de Oliveira
    International Journal of Molecular Sciences.2021; 22(9): 4339.     CrossRef

Diabetes Metab J : Diabetes & Metabolism Journal
Close layer
TOP